228 related articles for article (PubMed ID: 23103957)
1. Anti-inflammatory effect of electroacupuncture in the C3H/HeJ mouse model of alopecia areata.
Maeda T; Taniguchi M; Matsuzaki S; Shingaki K; Kanazawa S; Miyata S
Acupunct Med; 2013 Mar; 31(1):117-9. PubMed ID: 23103957
[No Abstract] [Full Text] [Related]
2. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
5. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
6. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model.
Nakamura M; Jo J; Tabata Y; Ishikawa O
Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811
[TBL] [Abstract][Full Text] [Related]
7. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata versus juvenile alopecia in C3H/HeJ mice: tools to dissect the role of inflammation in focal alopecia.
McElwee KJ; Boggess D; King LE; Sundberg JP
Exp Dermatol; 1999 Aug; 8(4):354-5. PubMed ID: 10439272
[No Abstract] [Full Text] [Related]
9. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes, neuropeptides, and genes involved in alopecia areata.
Gilhar A; Paus R; Kalish RS
J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634
[TBL] [Abstract][Full Text] [Related]
11. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
Freyschmidt-Paul P; Happle R; Hoffman R
J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
[TBL] [Abstract][Full Text] [Related]
12. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts.
McElwee KJ; Boggess D; King LE; Sundberg JP
J Invest Dermatol; 1998 Nov; 111(5):797-803. PubMed ID: 9804341
[TBL] [Abstract][Full Text] [Related]
13. Alopecia areata.
King LE; McElwee KJ; Sundberg JP
Curr Dir Autoimmun; 2008; 10():280-312. PubMed ID: 18460892
[TBL] [Abstract][Full Text] [Related]
14. Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes.
Hashimoto K; Yamada Y; Sekiguchi K; Matsuda S; Mori S; Matsumoto T
J Dermatol Sci; 2021 Jun; 102(3):177-183. PubMed ID: 33994063
[TBL] [Abstract][Full Text] [Related]
15. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management.
Paus R; Bulfone-Paus S; Bertolini M
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S12-S17. PubMed ID: 29273098
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
17. Alopecia areata: autoimmunity--the evidence is compelling.
Kalish RS; Gilhar A
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
[TBL] [Abstract][Full Text] [Related]
18. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
19. Transfer of Alopecia Areata to C3H/HeJ Mice Using Cultured Lymph Node-Derived Cells.
Wang EHC; Khosravi-Maharlooei M; Jalili RB; Yu R; Ghahary A; Shapiro J; McElwee KJ
J Invest Dermatol; 2015 Oct; 135(10):2530-2532. PubMed ID: 25946709
[No Abstract] [Full Text] [Related]
20. Role of neurogenic inflammation in the pathogenesis of alopecia areata.
Shi Y; Wan S; Song X
J Dermatol; 2024 May; 51(5):621-631. PubMed ID: 38605467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
